- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Current Price: $5.75
Takeda, which has agreed to market Orexigen’s anti-obesity drug, gained FDA approval for its type 2 diabetes treatment, influencing JMP Securities to view the development as positive for Orexigen. The firm has stated that it believe that the approval makes Takeda more likely to dedicate resources to cardiometabolic diseases in general. JMP Securities keeps its Outperform rating on the stock.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.